find your role first.

Raises

Kaigene raises $55M in its latest SEC filing

Kaigene
Raised in SEC filings
$56.3M
Filings
2
Latest est. round
Series B
Incorporated
2021
Industry
Biotechnology
Based in
MD

Every Form D filing

First saleAmount soldEst. round
2026-09-30$55MSeries B
2022-03-15$1.4MPre-seed/Seed

Named in the latest filing

From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR

Get this in your inbox

The daily read on who's hiring and who just raised, or one email a week. Free, one click to stop.